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Background
There are several studies indicating that histamine may
elicit modulatory influence on anxiety-related behaviours
both in animals and humans [1-4]. The activity of hista-
minergic pathways subserving corticolimbic structures is
enhanced in response to fear-evoking and other stressful
stimuli. The nucleus accumbens (NAc) belongs to the
mesolimbic system and is a major component of the ven-
tral striatum of rat. The elevated plus maze (EPM) was
used to assess anxiolytic behaviour.
Materials and methods
In the present study, the anxiolytic effect of bilateral injec-
tions of the histamine into the NAc was examined in the
EPM. histamin (0.01, 0.1, 1 microgram/rat), pyrilamine
and ranitidine (0.001, 0.01, 0.1, 1 microgram/rat) were
injected i.c.v. at the doses. Animals used in these experi-
ments were male Wistar rats weighing 220-280 g at the
time of surgery. Eight animals were used in each experi-
ment. Animals were bilaterally cannulated in the NAc by
stereotaxic instrument and were allowed to recover 1-
week before behavioral testing.
Results
Bilateral intra-NAc injections of the different doses of his-
tamine, pyrilamine and ranitidine increased the percent-
age of open arm time (%OAT) and open arm entries
(%OAE). The data may indicate that histamine produced
a significant anxiolytic effect without the significant
changes in the locomotor activity.
Conclusions
In conclusion, the NAc may be involved in histamine,
pyrilamine and ranitidine-induced anxiolytic behavior.
Generally we can conclude that effects of histaminergic
system of NAc anxiolytic is like behavior of neuromedola-
tory and via the effect on other neurotransmitors releas-
ing.
Acknowledgements
The authors are thankful to the Vice Chancellor of Research, Tehran Uni-
versity of Medical Sciences for financial support.
References
1. Zarrindast MR, Torabi M, Rostami P, Fazli-Tabaei S: The effects of
histaminergic agents in the dorsal hippocampus of rats in the
elevated plus-maze test of anxiety.  In Pharmacol Biochem Behav
Volume 85. Issue 3 Epub; 2006:500-6.  Nov Epub 2006 Nov 15
2. Rostami P, Hajizadeh-Moghaddam A, Zarrindast MR: The effects of
histaminergic agents in the ventral hippocampus of rats in
the plus-maze test of anxiety-like behaviours.  In Physiol Behav
Volume 87. Issue 5 Epub; 2006:891-6.  May 30 Epub 2006 Mar 6
3. Zarrindast MR, Moghadam AH, Rostami P, Roohbakhsh A: The
effects of histaminergic agents in the central amygdala of
rats in the elevated plus-maze test of anxiety.  Behav Pharmacol
2005, 16(8):643-9. Dec
4. Zarrindast MR, Rostami P, Zarei M, Roohbakhsh A: Intracerebrov-
entricular effects of histaminergic agents on morphine-
induced anxiolysis in the elevated plus-maze in rats.  Basic Clin
Pharmacol Toxicol 2005, 97(5):276-81. Nov
from International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour
Thessaloniki, Greece. 28 November – 2 December 2007
Published: 17 April 2008
Annals of General Psychiatry 2008, 7(Suppl 1):S225 doi:10.1186/1744-859X-7-S1-S225
<supplement> <title> <p>International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour</p> </title> <note>Meeting abstracts - A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1744-859X-7-S1-full.pdf">here</a>.</note> </supplement>
This abstract is available from: http://www.annals-general-psychiatry.com/content/7/S1/S225
© 2008 Shalmani et al.; licensee BioMed Central Ltd. 
